Učitavanje...
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis
Genetic variation at the chromosome 9p21 risk locus promotes cardiovascular disease; however, it is unclear how or which proteins encoded at this locus contribute to disease. We have previously demonstrated that loss of one candidate gene at this locus, cyclin-dependent kinase inhibitor 2B (Cdkn2b),...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Clinical Investigation
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3938254/ https://ncbi.nlm.nih.gov/pubmed/24531546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI70391 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|